Rocket Pharmaceuticals, Inc (RCKT) insider trading
Every open-market stock purchase and sale by Rocket Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $546K over the last 12 months (19 sales).
- Last insider buy: Elisabeth Bjork (Insider), $34.4K, 9 months ago.
Last 12 months: insiders bought $34.4K (1 buy) and sold $546K (19 sales). Last close $2.70 on Jun 7, 2026.
Recent RCKT insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| May 26, 2026 | John Militello (Insider) | Sold (not open market) | $1.1M |
| May 26, 2026 | John Militello (Insider) | Sold (not open market) | $998K |
| May 26, 2026 | John Militello (Insider) | Sold (not open market) | $737K |
| May 26, 2026 | John Militello (Insider) | Sold (not open market) | $514K |
| May 26, 2026 | John Militello (Insider) | Sold (not open market) | $454K |
| May 26, 2026 | John Militello (Insider) | Sold (not open market) | $379K |
| May 26, 2026 | John Militello (Insider) | Bought (not open market) | $155K |
| May 26, 2026 | John Militello (Insider) | Sold (not open market) | $109K |
| May 26, 2026 | John Militello (Insider) | Bought (not open market) | $74.7K |
| May 26, 2026 | John Militello (Insider) | Bought (not open market) | $48.2K |
| May 26, 2026 | John Militello (Insider) | Sold (not open market) | $47.8K |
| May 26, 2026 | John Militello (Insider) | Bought (not open market) | $45K |
| May 26, 2026 | John Militello (Insider) | Bought (not open market) | $27.3K |
| May 21, 2026 | Gaurav Shah (CEO) | Sold | $172K |
| May 21, 2026 | Gaurav Shah (CEO) | Bought (not open market) | $129K |
| May 19, 2026 | Gaurav Shah (CEO) | Sold | $7.3K |
| May 19, 2026 | Martin Wilson (General Counsel) | Sold | $2K |
| May 19, 2026 | John Militello (Insider) | Sold | $1.2K |
| May 13, 2026 | Martin Wilson (General Counsel) | Sold | $12.1K |
| May 13, 2026 | Gaurav Shah (CEO) | Sold | $9.8K |
| May 13, 2026 | John Militello (Insider) | Sold | $3.1K |
| May 7, 2026 | Sarbani Chaudhuri (Insider) | Sold | $67.7K |
| Feb 18, 2026 | Gaurav Shah (CEO) | Sold | $20K |
| Feb 18, 2026 | Martin Wilson (General Counsel) | Sold | $4.6K |
| Feb 18, 2026 | John Militello (Insider) | Sold | $3.9K |
Who's trading RCKT
- John Militello, Insider: sold $138K (9 sales), last May 26, 2026
- Gaurav Shah, CEO: sold $268K (6 sales), last May 21, 2026
- Martin Wilson, General Counsel: sold $64.2K (5 sales), last May 19, 2026
- Sarbani Chaudhuri, Insider: sold $67.7K (1 sale), last May 7, 2026
- Christopher James Stevens, COO: other filings, last Feb 11, 2026
- Syed Ali-aamir Rizvi, C-suite exec: other filings, last Feb 11, 2026
- Elisabeth Bjork, Insider: bought $34.4K (1 buy), last Jan 2, 2026
- Jonathan David Schwartz, Insider: sold $7.6K (1 sale), last Nov 18, 2025
Get free alerts when an insider at Rocket Pharmaceuticals, Inc files a new trade →